https://mtimes.net/article/1518 MTIMES Global en 2026-11-10T19:32:57.325Z US CPI Surpasses Expectations, Fueling Treasury Yields and December Tightening Concerns https://mtimes.net/article/1463 MTIMES Global en 2026-11-10T19:32:57.325Z Are Hedge Funds Finally Abandoning AI? Wall Street Fears the 'Narrow Exit' https://mtimes.net/article/1459 MTIMES Global en 2026-11-10T19:32:57.325Z U.S. Semiconductor Stocks Plunge 12%: AI Investment Bubble or Reappraisal of Overheating? https://mtimes.net/article/1445 MTIMES Global en 2026-11-10T19:32:57.325Z KOSPI Buffeted by US Midterms as Brokerages Split on Timing of Market Rebound https://mtimes.net/article/1517 MTIMES Global en 2026-11-10T08:49:15.345Z Bank of Japan Faces Dilemma as Weak Consumption and Market Volatility Complicate Rate Hike Path https://mtimes.net/article/1514 MTIMES Global en 2026-11-10T06:22:06.193Z AI Data Center Investments Face Funding Tests as Banks Tighten Lending Criteria https://mtimes.net/article/1511 MTIMES Global en 2026-11-10T05:01:54.579Z KEPCO technology has grown in anticipation of the nuclear power plant boom... When will performance improve? https://mtimes.net/article/1510 MTIMES Global en 2026-11-10T03:00:16.470Z Ingenia Therapeutics' Ophthalmic Candidate Advances to Late-Stage Global Trials Under MSD https://mtimes.net/article/1509 MTIMES Global en 2026-11-10T00:57:32.812Z Alteogen's Second-Largest Shareholder Invests 4.6 Billion Won Amid Stock Plunge; Shinhan Securities Calls Sell-off Excessive https://mtimes.net/article/1508 MTIMES Global en 2026-11-10T00:20:07.171Z HanAll Biopharma's IMVT-1402 Shows Efficacy in Treating Refractory Rheumatoid Arthritis https://mtimes.net/article/1507 MTIMES Global en 2026-11-09T23:57:25.386Z Retail Investors Bet on Market Rebound with 1 Trillion Won in Leveraged ETFs https://mtimes.net/article/1504 MTIMES Global en 2026-11-09T10:19:06.756Z AprilBio Targets 2027 for Triple Drug Candidate Licensing Deals https://mtimes.net/article/1501 MTIMES Global en 2026-11-09T07:19:56.287Z South Korea Considers 15-20% Ownership Cap for Crypto Exchanges, Impacting Major M&A Deals https://mtimes.net/article/1493 MTIMES Global en 2026-11-09T00:54:14.628Z Small Insight Research: WRT Poised for Record Growth Beyond Recovery https://mtimes.net/article/1489 MTIMES Global en 2026-11-09T00:04:47.503Z Taiwan Cuts Short-Sale Limits 90% and Deploys Stabilization Fund, While South Korea Relies on Margin Collateral Relief https://mtimes.net/ja/article/1518 MTIMES Global ja 2026-11-10T19:32:57.325Z 米CPIが予想を上回る、国債利回り上昇で12月の金融引き締め警戒感が高まる https://mtimes.net/ja/article/1463 MTIMES Global ja 2026-11-10T19:32:57.325Z ヘッジファンドのAI株売り逃げ開始か…ウォール街が恐れる「狭い出口」 https://mtimes.net/ja/article/1459 MTIMES Global ja 2026-11-10T19:32:57.325Z 米半導体株が12％急落…AI投資は崩壊か、過熱感の再評価か https://mtimes.net/ja/article/1445 MTIMES Global ja 2026-11-10T19:32:57.325Z 米中間選挙で揺れる韓国総合株価指数（KOSPI）、証券各社で見解が分かれる反発時期 https://mtimes.net/ja/article/1517 MTIMES Global ja 2026-11-10T08:49:15.345Z 日銀の利上げにジレンマ、物価上昇の一方で個人消費の急減と株安が重石に https://mtimes.net/ja/article/1514 MTIMES Global ja 2026-11-10T06:22:06.193Z AIデータセンター投資、資金調達が試練に…銀行が融資審査を強化 https://mtimes.net/ja/article/1511 MTIMES Global ja 2026-11-10T05:01:54.579Z 原発好況に期待大きくなった韓電技術…パフォーマンスの改善はいつですか？ https://mtimes.net/ja/article/1510 MTIMES Global ja 2026-11-10T03:00:16.470Z D&Dファーマテックから技術移転された眼科治療候補物質、米MSD主導で大規模グローバル後期臨床へ https://mtimes.net/ja/article/1509 MTIMES Global ja 2026-11-10T00:57:32.812Z アルテオジェン急落に46億ウォン投入した第2株主、新韓証券も「下げ過ぎ」と評価 https://mtimes.net/ja/article/1508 MTIMES Global ja 2026-11-10T00:20:07.171Z ハンオルバイオファーマの「アイメロフルバト」、難治性関節リウマチで有効性を実証 https://mtimes.net/ja/article/1507 MTIMES Global ja 2026-11-09T23:57:25.386Z 急落相場でレバレッジETFに1兆ウォンの買い越し…個人投資家が反発に賭ける https://mtimes.net/ja/article/1504 MTIMES Global ja 2026-11-09T10:19:06.756Z エイプリルバイオ、2027年までに新薬3種の技術移転を目指す「勝負手」 https://mtimes.net/ja/article/1501 MTIMES Global ja 2026-11-09T07:19:56.287Z 暗号資産取引所の大株主保有比率、15～20％に制限検討…NAVERや未来アセットのM&Aにも影響か https://mtimes.net/ja/article/1493 MTIMES Global ja 2026-11-09T00:54:14.628Z スモールインサイトリサーチ「ウォート、回復を超えて成長軌道へ」 https://mtimes.net/ja/article/1489 MTIMES Global ja 2026-11-09T00:04:47.503Z 台湾は空売り制限と22兆ウォンの安定基金投入へ、韓国の市場対応に温度差 https://mtimes.net/zh/article/1518 MTIMES Global zh-cn 2026-11-10T19:32:57.325Z 美国10月CPI超预期，国债收益率上升加剧12月紧缩警惕 https://mtimes.net/zh/article/1463 MTIMES Global zh-cn 2026-11-10T19:32:57.325Z 对冲基金的AI“大逃亡”开始了吗……华尔街恐惧的“狭窄出口”？ https://mtimes.net/zh/article/1459 MTIMES Global zh-cn 2026-11-10T19:32:57.325Z 美半导体暴跌12%…是AI投资崩溃，还是过热后的重估？ https://mtimes.net/zh/article/1445 MTIMES Global zh-cn 2026-11-10T19:32:57.325Z 美中期选举致韩国综合股价指数剧烈波动 证券界对反弹时点预测不一 https://mtimes.net/zh/article/1517 MTIMES Global zh-cn 2026-11-10T08:49:15.345Z 日本央行陷入加息困境：通胀压力与股市动荡并存 https://mtimes.net/zh/article/1514 MTIMES Global zh-cn 2026-11-10T06:22:06.193Z AI数据中心投资、融资试验台……银行加强贷款筛选 https://mtimes.net/zh/article/1511 MTIMES Global zh-cn 2026-11-10T05:01:54.579Z KEPCO 技术在核电站繁荣的预期中不断发展......性能何时会提高？ https://mtimes.net/zh/article/1510 MTIMES Global zh-cn 2026-11-10T03:00:16.470Z Ingenia Therapeutics抗体药物获默沙东推进，全球后期临床试验规模达数千人 https://mtimes.net/zh/article/1509 MTIMES Global zh-cn 2026-11-10T00:57:32.812Z Alteogen股价大跌之际二大股东投入46亿增持，新韩证券称跌幅过 https://mtimes.net/zh/article/1508 MTIMES Global zh-cn 2026-11-10T00:20:07.171Z 韩奥生物制药IMVT-1402在难治性类风湿关节炎临床试验中展现疗效 https://mtimes.net/zh/article/1507 MTIMES Global zh-cn 2026-11-09T23:57:25.386Z 股市剧烈震荡下个人投资者大举买入杠杆ETF，押注反弹行情 https://mtimes.net/zh/article/1504 MTIMES Global zh-cn 2026-11-09T10:19:06.756Z AprilBio计划在2027年前实现三款新药的早期技术转让 https://mtimes.net/zh/article/1501 MTIMES Global zh-cn 2026-11-09T07:19:56.287Z 虚拟资产交易所拟限制大股东持股比例至15-20%，Naver与未来资产并购案受关注 https://mtimes.net/zh/article/1493 MTIMES Global zh-cn 2026-11-09T00:54:14.628Z 小巨人洞察研究所：“沃特超越复苏，迈入成长轨道” https://mtimes.net/zh/article/1489 MTIMES Global zh-cn 2026-11-09T00:04:47.503Z 台湾大幅收紧融券限额并动用稳定基金，韩国股市暴跌下为何仅放宽担保限制？